CORRECTION: Addex Therapeutics Q2 EPADS $(2.16) Up From $(2.90) YoY, Sales $12.650K Down From $44.031K YoY

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(2.16) per share. This is a 25.52 percent increase over losses of $(2.90) per share from the same period last year. The company reported $12.650 thousand in sales this quarter. This is a 71.27 percent decrease over sales of $44.031 thousand the same period last year.